Some analysts believe the global GLP-1 market could exceed $100 billion annually within the next decade
Request A Free Case Review From A NAION Injury Lawyer NAION Eye Injury Lawsuit & Settlement Cases NAION lawsuit and settlement cases potentially being investigated include claims of individuals who, after taking Ozempic, Wegovy or other semaglutide or GLP-1 medications to treat diabetes or obesity, were diagnosed with non-arteritic anterior ischemic optic neuropathy: Non-arteritic anterior ischemic optic neuropathy NAION Non-arteritic AION Ischemic optic neuropathy Papillitis ischemica Anterior ischemic optic neuropathy (AION): Eye stroke Optic disc infarction Disc edema with ischemic etiology Optic nerve damage Sudden vision loss Blindness Other eye injury lawsuit cases If you or someone you love took Ozempic, Wegovy, or other GLP-1 medications and were later diagnosed with NAION, you may qualify to recover money from an Ozempic NAION lawsuit or settlement case
Insurance does not cover lipotropic injections because they are classified as wellness or weight management interventions rather than medically necessary treatments
This detailed comparison breaks down effectiveness, side effects, costs, and which medication might be right for you
10.2337/dc15-2479 [DOI] [PubMed] [Google Scholar] 170.Pratley RE, Nauck MA, Barnett AH, Feinglos MN, Ovalle F, Harman-Boehm I, et al
